PPT-MM-005: A Phase 1, Multicenter, Open-Label, Dose-Escalation Study
to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide Bortezomib and Low Dose Dexamethasone in Patients with Relapsed or RelapsedRefractory
Download Presentation
"MM-005: A Phase 1, Multicenter, Open-Label, Dose-Escalation …" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.